The authors wish to change the affiliation details of Eloisa Jantus-Lewintre as follows: 20Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation; Department of Biotechnology, Univeristat Politècnica de València; CIBERONC, Spain. The authors take sole responsibility for this notice and would like to apologize to readers and editors of CROH for any inconvenience that it may have caused in the publication process of the article.
Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978)) / Rolfo, C.; Cardona, A. F.; Cristofanilli, M.; Paz-Ares, L.; Diaz Mochon, J. J.; Duran, I.; Raez, L. E.; Russo, A.; Lorente, J. A.; Malapelle, U.; Gil-Bazo, I.; Jantus-Lewintre, E.; Pauwels, P.; Mok, T.; Serrano, M. J.. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 154:(2020), p. 103058. [10.1016/j.critrevonc.2020.103058]
Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))
Malapelle U.;
2020
Abstract
The authors wish to change the affiliation details of Eloisa Jantus-Lewintre as follows: 20Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation; Department of Biotechnology, Univeristat Politècnica de València; CIBERONC, Spain. The authors take sole responsibility for this notice and would like to apologize to readers and editors of CROH for any inconvenience that it may have caused in the publication process of the article.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
